{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:23:54Z","timestamp":1794029034311,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":214,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016016","name":"Gilead Sciences Europe Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101091","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:13:41Z","timestamp":1786115621000},"page":"101091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health Disparities in Hepatitis D Virus Management: A Case Series on Improving Patient Access to Bulevirtide Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Ahmed","family":"Elsharkawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Horobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sital","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2026.101091_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jvh.13891","article-title":"The elimination of hepatitis D as a public health problem: needs and challenges","volume":"31","author":"Vanwolleghem","year":"2024","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastha.2026.101091_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.gastha.2026.101091_bib3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gastha.2026.101091_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"73","author":"Alfaiate","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101091_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101091_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13690-021-00693-2","article-title":"The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?","volume":"79","author":"Hayashi","year":"2021","journal-title":"Arch Public Health"},{"key":"10.1016\/j.gastha.2026.101091_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/liv.15106","article-title":"Hepatitis delta virus in migrants: the challenge of elimination (ANRS CO22 HEPATHER cohort)","volume":"42","author":"Lotto","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.gastha.2026.101091_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL Clinical Practice guidelines on hepatitis delta virus","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101091_bib9","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2020-323888","article-title":"Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease","volume":"70","author":"Urban","year":"2021","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.gastha.2026.101091_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/liv.14838","article-title":"New therapies for hepatitis delta virus infection","volume":"41","author":"Loureiro","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.gastha.2026.101091_bib12","series-title":"Bulevirtide for treating chronic hepatitis D","year":"2023"},{"key":"10.1016\/j.gastha.2026.101091_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa2213429","article-title":"A phase 3, randomized trial of bulevirtide in chronic hepatitis D","volume":"389","author":"Wedemeyer","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastha.2026.101091_bib14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/pharmaceutics13071100","article-title":"Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research","volume":"13","author":"Kvarnstr\u00f6m","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.gastha.2026.101091_bib15","first-page":"1115","article-title":"Epidemiology pattern, prevalent genotype distribution, fighting stigma and control options for hepatitis D in Bulgaria and other European countries","volume":"13","author":"Tsaneva-Damyanova","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.gastha.2026.101091_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/v17010052","article-title":"Unveiling prevalence, risk factors, and outcomes of hepatitis D among vulnerable communities in Romania","volume":"17","author":"Gheorghe","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.gastha.2026.101091_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1993066","article-title":"Medicine adherence and associated factors in immigrants and refugees: a systematic review","volume":"2022","author":"Patel","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.gastha.2026.101091_bib18","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.2105\/AJPH.2015.302903","article-title":"Implicit racial\/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review","volume":"105","author":"Hall","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.gastha.2026.101091_bib19","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s10620-019-05877-z","article-title":"Provider perceptions of hepatitis C treatment adherence and initiation","volume":"65","author":"Zhang","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastha.2026.101091_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.12968\/bjon.2024.33.Sup20.S1","article-title":"A service model guide to outpatient parenteral antimicrobial therapy (OPAT)","volume":"33","author":"Zhang","year":"2024","journal-title":"Br J Nurs"},{"key":"10.1016\/j.gastha.2026.101091_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.amjmed.2023.03.007","article-title":"Patient-tailored interventions to improve specialty medication adherence: results from a prospective randomized controlled trial","volume":"136","author":"Kibbons","year":"2023","journal-title":"Am J Med"},{"key":"10.1016\/j.gastha.2026.101091_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/psb.1275","article-title":"Improving adherence needs a multipronged approach","volume":"25","author":"Elliott","year":"2014","journal-title":"Prescriber"},{"key":"10.1016\/j.gastha.2026.101091_bib23","series-title":"Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence","year":"2009"},{"key":"10.1016\/j.gastha.2026.101091_bib24","first-page":"106","article-title":"Medication adherence and compliance: recipe for improving patient outcomes","volume":"10","author":"Aremu","year":"2022","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.gastha.2026.101091_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/medicina61010153","article-title":"Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life","volume":"61","author":"Religioni","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.gastha.2026.101091_bib26","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.5993\/AJHB.31.s1.16","article-title":"Integrating literacy, culture, and language to improve health care quality for diverse populations","volume":"31","author":"Andrulis","year":"2007","journal-title":"Am J Health Behav"},{"key":"10.1016\/j.gastha.2026.101091_bib27","series-title":"Shaping hepatitis D treatment pathways: leveraging the pharmacy team roles","author":"Shah","year":"2024"},{"key":"10.1016\/j.gastha.2026.101091_bib28","doi-asserted-by":"crossref","DOI":"10.5888\/pcd17.200324","article-title":"Needs of individuals living with hepatitis delta virus and their caregivers, 2016-2019","volume":"17","author":"Kumar","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.gastha.2026.101091_bib29","series-title":"Breaking the silence: combating stigma and misinformation in the fight against hepatitis","year":"2024"},{"key":"10.1016\/j.gastha.2026.101091_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jhep.2024.05.001","article-title":"Bulevirtide monotherapy in patients with chronic HDV: efficacy and safety results through week 96 from a phase III randomized trial","volume":"81","author":"Wedemeyer","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101091_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2471\/BLT.20.260919","article-title":"Improving care of migrants is key for viral hepatitis elimination in Europe","volume":"99","author":"Kim","year":"2021","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.gastha.2026.101091_bib32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1136\/bmj.p1875","article-title":"What NHS services are migrants entitled to?","volume":"382","author":"Wurie","year":"2023","journal-title":"BMJ"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326002128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326002128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:25:01Z","timestamp":1794025501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326002128"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101091","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Disparities in Hepatitis D Virus Management: A Case Series on Improving Patient Access to Bulevirtide Therapy","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101091"}}